Viewing Study NCT04036435


Ignite Creation Date: 2025-12-24 @ 10:10 PM
Ignite Modification Date: 2026-01-25 @ 3:52 AM
Study NCT ID: NCT04036435
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-10-20
First Post: 2019-07-25
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Long-Term Study That Measures the Safety and Efficacy of Deucravacitinib (BMS-986165) in Participants With Psoriasis
Sponsor: Bristol-Myers Squibb
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Psoriasis View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Psoriasis View